Laurus Labs Limited
LAURUSLABS
Rank in Stocks
#1757
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Share Price
$22.72
Last synced: 2026-10-16
Market Cap
$12.27B
Change (1 day)
1.91%
Change (1 year)
122.18%
Country
IN
Trade Laurus Labs Limited (LAURUSLABS)
Category
Healthcare
EPS for Laurus Labs Limited (LAURUSLABS)
EPS as of June 2026 TTM: $0.22
According to Laurus Labs Limited latest financial reports and stock price the company's current EPS (TTM) is $0.22. At the end of 2024 the company had a EPS of $0.04 a decrease compared to its 2023 EPS that were of $0.18.
EPS history for Laurus Labs Limited from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.22 | 179.38% |
| 2025 | $0.08 | 117.93% |
| 2024 | $0.04 | -80.03% |
| 2023 | $0.18 | -11.96% |
| 2022 | $0.20 | -19.02% |
| 2021 | $0.25 | 294.34% |
| 2020 | $0.06 | 149.41% |
| 2019 | $0.03 | -47.64% |
| 2018 | $0.05 | -24.02% |
| 2017 | $0.06 | -0.62% |
| 2016 | $0.06 | 82.20% |
| 2015 | $0.04 | -4.07% |
| 2014 | $0.04 | -30.64% |
| 2013 | $0.05 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 148.90% |
IN
|
